Further studies are needed to better understand the mechanisms by which AMBRA1-mediated mitophagy is initiated and to determine whether AMBRA1-mediated mitophagy could be pharmacologically induced in vivo in order to ameliorate the mitochondrial defects observed in human dopaminergic neurons in models of PD. This evidence concerns the gene AMBRA1 and Parkinson disease.